In T cells, Sirt1 enhances the activity of Foxo1 by deacetylating Foxo1, and promotes the expression of Klf2 and Ccr7 genes, thereby improving the anti-tumor immune response of T cells (Chatterjee et al., 2018). The gene discussed is FOXO1; the disease is neoplasm.